EUVIMEDEUVIMED entdecken
Crossref

L26/P-533 Rescuing low serum progesterone restores pregnancy outcomes in HRT-FET cycles among women with recurrent implantation failure

N.T.L. Huong, P. Ngọc Quý, P.T.T. Anh, G.T.M. Phuong, N.T. Hong, N.T.K.C. Cuc, D.T. Taang, D.T.T. Trang, P.T. Anh, H.B. Long, L. Hoang

Human Reproduction · 01.07.2026 · 41 (Supplement_1)

DOI: 10.1093/humrep/deag083.866 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von N.T.L. Huong und 10 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Study question Does progesterone rescue for low serum progesterone normalize pregnancy outcomes in hormonally prepared frozen embryo transfer cycles among women with recurrent implantation failure? Summary answer Progesterone rescue in low-progesterone HRT-FET cycles restores pregnancy outcomes in women with recurrent implantation failure to levels comparable with adequate progesterone cycles. What is known already Low serum progesterone levels before embryo transfer in HRT-FET cycles are associated with impaired implantation and reduced pregnancy outcomes. Rescue strategies include increasing the vaginal progesterone dose or switching formulations (vaginal gel), adding oral progestins, and supplementing progesterone via parenteral routes. Among these approaches, intramuscular progesterone has shown the most consistent evidence; it rapidly normalizes progesterone levels and may restore pregnancy outcomes. However, evidence specifically focusing on women with recurrent implantation failure (RIF)—a subgroup with limited therapeutic options and a high clinical burden—remains scarce. Whether progesterone rescue can effectively normalize pregnancy outcomes in this challenging population, therefore, remains uncertain. Study design, size, duration This retrospective cohort study included 202 HRT-FET cycles in women with recurrent implantation failure conducted at a single IVF center from January 2023 to December 2025. Each patient contributed one independent cycle. Participants/materials, setting, methods All patients received vaginal micronized progesterone combined with oral dydrogesterone. Serum progesterone was measured one day before embryo transfer. Cycles with progesterone <10 ng/mL received rescue supplementation, while cycles with progesterone ≥10 ng/mL proceeded without intervention. The primary outcome was ongoing pregnancy beyond 12 weeks. Inverse probability of treatment weighting based on a propensity score was used to balance baseline characteristics. Multiple sensitivity analyses were performed. Main results and the role of chance After inverse probability of treatment weighting, baseline characteristics were well balanced between groups, with all standardized mean differences below 0.10. Ongoing pregnancy rates in the rescue group were comparable to those observed in cycles with adequate progesterone (OR 1.37, 95% confidence interval 0.77–2.45). No statistically significant differences were detected for positive pregnancy test, clinical pregnancy, or early pregnancy loss. Findings were consistent across extensive sensitivity analyses, including multivariable adjustment, doubly robust models, weight truncation, overlap weighting, propensity score trimming, and an alternative propensity score specification using progesterone dose as an age proxy. The E-value for the point estimate of the primary outcome was 2.09, indicating that a moderately strong unmeasured confounder would be required to fully explain the observed association. Overall, results support a normalization of pregnancy outcomes following progesterone rescue rather than evidence of superiority. Limitations, reasons for caution The retrospective design limits causal inference, and no untreated low-progesterone group was available for ethical and clinical reasons. Residual confounding cannot be completely excluded despite comprehensive adjustment and sensitivity analyses. Wider implications of the findings The retrospective design limits causal inference, and no untreated low-progesterone group was available for ethical and clinical reasons. Residual confounding cannot be completely excluded despite comprehensive adjustment and sensitivity analyses. Trial registration number No

Zitieren

APA

Huong, N., Quý, P. N., Anh, P., Phuong, G., Hong, N., Cuc, N., Taang, D., Trang, D., Anh, P., Long, H., & Hoang, L. (2026). L26/P-533 Rescuing low serum progesterone restores pregnancy outcomes in HRT-FET cycles among women with recurrent implantation failure. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.866

Vancouver

Huong N, Quý PN, Anh P, Phuong G, Hong N, Cuc N, et al. L26/P-533 Rescuing low serum progesterone restores pregnancy outcomes in HRT-FET cycles among women with recurrent implantation failure. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.866

BibTeX
@article{Huong2026,
  author = {Huong, N.T.L. and Quý, P. Ngọc and Anh, P.T.T. and Phuong, G.T.M. and Hong, N.T. and Cuc, N.T.K.C. and Taang, D.T. and Trang, D.T.T. and Anh, P.T. and Long, H.B. and Hoang, L.},
  title = {L26/P-533 Rescuing low serum progesterone restores pregnancy outcomes in HRT-FET cycles among women with recurrent implantation failure},
  journal = {Human Reproduction},
  year = {2026},
  volume = {41},
  number = {Supplement_1},
  doi = {10.1093/humrep/deag083.866}
}
Kostenlos starten →